Literature DB >> 3169061

Long-term course of schizoaffective disorders. Part I: Definitions, methods, frequency of episodes and cycles.

A Marneros1, A Deister, A Rohde, H Jünemann, R Fimmers.   

Abstract

The present study (Cologne study) investigated the long-term course (means = 25.6 years, minimum 10, maximum 59 years) of 72 schizoaffective patients. The diagnosis was based on the longitudinal approach. All patients were interviewed personally, using the Present State Examination and a pool of questions based on some instruments of the WHO (DAS, PIRS, etc.). The course was found to be usually polyphasic (more than 3 episodes) and only exceptionally monophasic (1 episode). For the purposes of statistical analysis an episode was considered in terms of time between the beginning and ending of inpatient or inpatient-like treatment. The number of episodes and cycles were found to be independent from premorbid and sociodemographic variables. But a significant relation was found between number of episodes (and cycles) and (a) polarity of the affective symptomatology, (b) presence of psychotic productive symptoms, (c) polymorphous course, (d) age at onset, and (e) duration of activity of the illness. It can be said that schizoaffective disorders are recurrent whereby the frequency of relapses is higher in bipolar than in unipolar types.

Entities:  

Mesh:

Year:  1988        PMID: 3169061     DOI: 10.1007/bf00450545

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  17 in total

1.  Schizoaffective disorders. Results of a genetic investigation, I.

Authors:  J Angst; W Felder; B Lohmeyer
Journal:  J Affect Disord       Date:  1979-06       Impact factor: 4.839

2.  The course of monopolar depression and bipolar psychoses.

Authors:  J Angst; P Baastrup; P Grof; H Hippius; W Pöldinger; P Weis
Journal:  Psychiatr Neurol Neurochir       Date:  1973 Nov-Dec

3.  [Course of unipolar depressive, bipolar manic-depressive, and schizoaffective disorders. Results of a prospective longitudinal study (author's transl)].

Authors:  J Angst
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1980-01

4.  [Do 1st rank symptoms establish the diagnosis of schizophrenia? On the significance of clinical correlations and the limits of criteria].

Authors:  A Marneros
Journal:  Nervenarzt       Date:  1984-07       Impact factor: 1.214

5.  Schizoaffective disorder: concept and reality.

Authors:  M T Tsuang; J C Simpson
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

6.  Frequency of occurrence of Schneider's first rank symptoms in Schizophrenia.

Authors:  A Marneros
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

7.  Long-term course of schizoaffective disorders. Part II: Length of cycles, episodes, and intervals.

Authors:  A Marneros; A Rohde; A Deister; H Jünemann; R Fimmers
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

8.  Schizophrenic first-rank symptoms in organic mental disorders.

Authors:  A Marneros
Journal:  Br J Psychiatry       Date:  1988-05       Impact factor: 9.319

9.  An approach to the diagnosis and classification of schizoaffective disorders for research purposes.

Authors:  M Maj; C Perris
Journal:  Acta Psychiatr Scand       Date:  1985-11       Impact factor: 6.392

10.  Schizophrenia suspecta.

Authors:  A Marneros; A Deister; N Diederich; A Rohde
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984
View more
  18 in total

1.  Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndromes: results from a twenty-year prospective community study.

Authors:  Wulf Rössler; Jules Angst; Alex Gamma; Helene Haker; Niklaus Stulz; Kathleen R Merikangas; Vladeta Ajdacic-Gross
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-13       Impact factor: 5.270

2.  Unipolar and bipolar schizoaffective disorders: a comparative study. I. Premorbid and sociodemographic features.

Authors:  A Marneros; A Deister; A Rohde
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

3.  Unipolar and bipolar schizoaffective disorders: a comparative study. II. Long-term course.

Authors:  A Marneros; A Rohde; A Deister
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

4.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. II. Causal-analytical investigations.

Authors:  E M Steinmeyer; A Marneros; A Deister; A Rohde; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. I. Definitions, methods, psychopathological and social outcome.

Authors:  A Marneros; A Deister; A Rohde; E M Steinmeyer; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

6.  Long-term course of schizoaffective disorders. Part III: Onset, type of episodes and syndrome shift, precipitating factors, suicidality, seasonality, inactivity of illness, and outcome.

Authors:  A Marneros; A Rohde; A Deister; R Fimmers; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

Review 7.  The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

8.  Subtypes in schizophrenic disorders: frequencies in long-term course and premorbid features.

Authors:  A Deister; A Marneros
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-08       Impact factor: 4.328

9.  Long-term stability of subtypes in schizophrenic disorders: a comparison of four diagnostic systems.

Authors:  A Deister; A Marneros
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

10.  Stability of diagnoses in affective, schizoaffective and schizophrenic disorders. Cross-sectional versus longitudinal diagnosis.

Authors:  A Marneros; A Deister; A Rohde
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.